25.02
0.35%
0.0829
Pfizer Inc (PFE) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 | 2024-03-31 | 2023-12-31 | 2023-10-01 | 2023-07-02 | 2023-04-02 |
期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
Revenues |
4.42%
14,879.00
|
14,249.00 | 13,232.00 | 12,734.00 | 18,282.00 |
Cost Of Revenue |
55.32%
3,379.00
|
7,563.00 | 9,269.00 | 3,237.00 | 4,886.00 |
Gross Profit |
72.00%
11,500.00
|
6,686.00 | 3,963.00 | 9,497.00 | 13,396.00 |
Operating Expenses
|
25.30%
8,079.00
|
10,815.00 | 7,315.00 | 7,228.00 | 7,126.00 |
Interest Income/Expense |
14.83%
790.00
|
688.00 | 695.00 | 508.00 | 318.00 |
Benefits Costs and Expenses |
37.65%
11,458.00
|
18,378.00 | 16,584.00 | 10,465.00 | 12,012.00 |
Costs And Expenses |
37.65%
11,458.00
|
18,378.00 | 16,584.00 | 10,465.00 | 12,012.00 |
Operating Income/Loss |
182.85%
3,421.00
|
-4,129.00 | -3,352.00 | 2,269.00 | 6,270.00 |
Income/Loss From Continuing Operations Before Tax |
182.85%
3,421.00
|
-4,129.00 | -3,352.00 | 2,269.00 | 6,270.00 |
Income Tax Expense/Benefit, Deferred |
76.26%
-441.00
|
-1,858.00 | -113.00 | -873.00 | -598.00 |
Income Tax Expense/Benefit |
136.86%
293.00
|
-795.00 | -964.00 | -71.00 | 715.00 |
Income/Loss From Continuing Operations After Tax |
193.79%
3,128.00
|
-3,335.00 | -2,388.00 | 2,340.00 | 5,555.00 |
Income/Loss From Discontinued Operations, Net Of Tax |
80.77%
-5.00
|
-26.00 | 12.00 | -2.00 | 1.00 |
Net Income/Loss
|
192.95%
3,123.00
|
-3,360.00 | -2,376.00 | 2,338.00 | 5,556.00 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
11.11%
8.00
|
9.00 | 6.00 | 11.00 | 13.00 |
Basic Average Shares |
565.60K%
5,657.00
|
1.00 | 5,646.00 | 5,646.00 | 5,634.00 |
Diluted Average Shares |
114.04K%
5,697.00
|
-5.00 | 5,646.00 | 5,713.00 | 5,727.00 |
Basic Earnings Per Share |
193.22%
0.55
|
-0.59 | -0.42 | 0.41 | 0.98 |
Diluted Earnings Per Share |
193.22%
0.55
|
-0.59 | -0.42 | 0.41 | 0.97 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
大文字化:
|
ボリューム (24 時間):